Murrieta Genomics
Leila Colgan is an experienced professional in the oncology and biotechnology sectors, currently serving as a Precision Medicine Liaison at Novartis Oncology since April 2022. With a proven track record in business development and sales, Leila has held significant positions such as Sales and Marketing Advisor at Murrieta Genomics and Director of Business Development at CureMatch, Inc. Previous roles include Senior Oncology Account Manager at Sun Pharma, Vice President Sales and Marketing at MYnd Analytics Inc., and National Genomic Sales Director at Trovagene, contributing to substantial revenue growth and successful product launches. Leila's educational background includes an MBA from Pepperdine Graziadio Business School and a B.A. in Psychology from Pepperdine University.
This person is not in any teams
This person is not in any offices
Murrieta Genomics
Murrieta Genomics is dedicated to advancing the use of genomic sequencing in precision medicine, agriculture, forensics, veterinary and direct to consumer applications by offering entrepreneurs access to the specialized equipment, know-how and mentors that can transform research into commercial enterprise. We are a true incubator, offering dedicated bench space to fledgling companies at basically zero cost, helping them to define their business model and validate their science, and then investing in the companies that “graduate” the incubator. We are located in the 16,000 square foot Murrieta Innovation Center in Southern California, in close proximity to Los Angeles, San Diego and Orange County. We welcome inquiries from researchers, entrepreneurs, scientists, investors, and business professionals who share our passion for advancing science and sparking economic development.